|
US4873192A
(en)
|
1987-02-17 |
1989-10-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Process for site specific mutagenesis without phenotypic selection
|
|
NZ227684A
(en)
|
1988-01-30 |
1991-07-26 |
Merck Sharp & Dohme |
Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions
|
|
GB9005737D0
(en)
|
1990-03-14 |
1990-05-09 |
Beecham Group Plc |
Novel compounds
|
|
FR2676444B1
(fr)
|
1991-05-16 |
1995-03-10 |
Sanofi Elf |
Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
|
|
EP1191097A1
(en)
|
2000-09-21 |
2002-03-27 |
Leids Universitair Medisch Centrum |
Induction of exon skipping in eukaryotic cells
|
|
EP1440311B1
(en)
|
2001-08-31 |
2009-01-07 |
Gen-Probe Incorporated |
Affinity-shifted probes for quantifying analyte polynucleotides
|
|
US7135484B2
(en)
|
2002-08-14 |
2006-11-14 |
Abbott Laboratories |
Azabicyclic compounds are central nervous system active agents
|
|
DE60326894D1
(de)
|
2002-09-30 |
2009-05-07 |
Neurosearch As |
1,4-Diazabicycloalkanderivate, deren Herstellung und Verwendung
|
|
US8014953B2
(en)
|
2003-08-08 |
2011-09-06 |
The Regents Of The University Of California |
RNA surveillance among curated proteins
|
|
US7399765B2
(en)
|
2003-09-19 |
2008-07-15 |
Abbott Laboratories |
Substituted diazabicycloalkane derivatives
|
|
US7160876B2
(en)
|
2003-12-22 |
2007-01-09 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
|
US7309699B2
(en)
|
2003-12-22 |
2007-12-18 |
Abbott Laboratories |
3-Quinuclidinyl amino-substituted biaryl derivatives
|
|
US7655657B2
(en)
|
2003-12-22 |
2010-02-02 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
|
US7309487B2
(en)
|
2004-02-09 |
2007-12-18 |
George Inana |
Methods and compositions for detecting and treating retinal diseases
|
|
AR049401A1
(es)
|
2004-06-18 |
2006-07-26 |
Novartis Ag |
Aza-biciclononanos
|
|
GB0415746D0
(en)
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
|
JP5635727B2
(ja)
|
2004-10-07 |
2014-12-03 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
チアゾリルｍｇｌｕｒ５アンタゴニスト及びそれらの使用のための方法
|
|
MX2007004551A
(es)
|
2004-10-18 |
2007-05-23 |
Amgen Inc |
Compuestos tiadiazol y metodos de uso.
|
|
US7838657B2
(en)
|
2004-12-03 |
2010-11-23 |
University Of Massachusetts |
Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences
|
|
ES2336243T3
(es)
|
2005-01-26 |
2010-04-09 |
Schering Corporation |
Derivados de 3-(indazol-5-il)-(1,2,4)triazina y composiciones similares como inhibidores de proteina quinasa para el tratamiento del cancer.
|
|
CA2606288A1
(en)
|
2005-04-18 |
2006-10-26 |
Neurogen Corporation |
Subtituted heteroaryl cb1 antagonists
|
|
US7598052B2
(en)
|
2005-10-11 |
2009-10-06 |
The Regents Of The University Of Michigan |
Expression profile of thyroid cancer
|
|
US8603457B2
(en)
|
2005-12-02 |
2013-12-10 |
University Of Rochester |
Nonsense suppression and genetic codon alteration by targeted modification
|
|
US7834178B2
(en)
|
2006-03-01 |
2010-11-16 |
Bristol-Myers Squibb Company |
Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
|
|
AU2007253950B2
(en)
|
2006-05-19 |
2012-05-03 |
Abbott Laboratories |
CNS active fused bicycloheterocycle substituted azabicyclic alkane derivatives
|
|
CN101426790B
(zh)
|
2006-05-30 |
2012-03-14 |
神经研究公司 |
1,4-二氮杂-双环[3.2.2]壬基二唑基衍生物和它们的医药用途
|
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
|
US8343941B2
(en)
|
2007-03-30 |
2013-01-01 |
Rutgers, The State University Of New Jersey |
Compositions and methods for gene silencing
|
|
US8283116B1
(en)
|
2007-06-22 |
2012-10-09 |
Ptc Therapeutics, Inc. |
Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
|
|
DE102007032507A1
(de)
*
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
PT2203173E
(pt)
|
2007-10-26 |
2016-03-15 |
Academisch Ziekenhuis Leiden |
Resumo
|
|
WO2009067579A1
(en)
|
2007-11-21 |
2009-05-28 |
Abbott Laboratories |
Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
|
|
US8437067B2
(en)
|
2008-03-18 |
2013-05-07 |
Konica Minolta Holdings, Inc. |
Electrochemical display element
|
|
US8633019B2
(en)
|
2008-05-27 |
2014-01-21 |
Ptc Therapeutics, Inc. |
Methods for treating spinal muscular atrophy
|
|
US8133724B2
(en)
|
2008-09-17 |
2012-03-13 |
University Of Maryland, Baltimore |
Human androgen receptor alternative splice variants as biomarkers and therapeutic targets
|
|
US8541424B2
(en)
|
2008-12-23 |
2013-09-24 |
Abbott Laboratories |
Anti-viral compounds
|
|
MX2011009751A
(es)
|
2009-03-16 |
2011-09-29 |
Opko Curna Llc |
Tratamiento de enfermedades relacionadas con factor nuclear (eritroide derivado 2) tipo 2 (nrf2) por inhibicion del transcrito antisentido natural a nrf2.
|
|
EP2417257B1
(en)
|
2009-04-10 |
2016-03-09 |
Association Institut de Myologie |
Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease
|
|
NZ597071A
(en)
|
2009-06-17 |
2014-05-30 |
Isis Pharmaceuticals Inc |
Compositions and methods for modulation of smn2 splicing in a subject
|
|
JO3250B1
(ar)
|
2009-09-22 |
2018-09-16 |
Novartis Ag |
إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
|
|
EP2305679A1
(en)
|
2009-09-28 |
2011-04-06 |
GenKyoTex SA |
Pyrazoline dione derivatives as nadph oxidase inhibitors
|
|
AR079724A1
(es)
*
|
2010-01-20 |
2012-02-15 |
Abbott Lab |
Metodos para el tratamiento del dolor
|
|
CN102822150B
(zh)
|
2010-02-05 |
2014-12-03 |
赫普泰雅治疗有限公司 |
1,2,4-三嗪-4-胺衍生物
|
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
US9133123B2
(en)
|
2010-04-23 |
2015-09-15 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
US8802642B2
(en)
|
2010-04-28 |
2014-08-12 |
Iowa State University Research Foundation, Inc. |
Spinal muscular atrophy treatment via targeting SMN2 catalytic core
|
|
JP6069661B2
(ja)
|
2010-06-24 |
2017-02-01 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
種々のアミロイドβペプチドアロフォームレベルの調節における組成物及びその使用
|
|
CA2806341C
(en)
|
2010-07-29 |
2020-03-24 |
Rigel Pharmaceuticals, Inc. |
Ampk-activating heterocyclic compounds and methods for using the same
|
|
SG10201703576WA
(en)
|
2011-03-14 |
2017-06-29 |
Nse Products Inc |
Oral formulations for promoting cellular purification
|
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
WO2013019938A1
(en)
|
2011-08-02 |
2013-02-07 |
The Brigham And Women's Hospital, Inc. |
Pyridazine derivatives as eaat2 activators
|
|
EP2771069A4
(en)
|
2011-10-27 |
2015-08-26 |
Mayo Foundation |
INHIBITION OF G-PROTEIN-COUPLED RECEPTOR-6-KINASE POLYPEPTIDE
|
|
CN104244944B
(zh)
|
2011-12-30 |
2018-06-08 |
Ptc医疗公司 |
用于治疗脊髓性肌萎缩症的化合物
|
|
JP6193888B2
(ja)
|
2012-01-26 |
2017-09-06 |
ピーティーシー セラピューティクス， インコーポレイテッド |
脊髄性筋萎縮症を治療するための化合物
|
|
WO2013117693A1
(en)
|
2012-02-10 |
2013-08-15 |
Glaxosmithkline Intellectual Property Development Limited |
Pde4 inhibitor for treating huntington's disease
|
|
PL2812004T3
(pl)
|
2012-02-10 |
2019-01-31 |
Ptc Therapeutics, Inc. |
Związki do leczenia rdzeniowego zaniku mięśni
|
|
CN104302181B
(zh)
|
2012-03-01 |
2017-09-15 |
Ptc医疗公司 |
用于治疗脊髓性肌萎缩的化合物
|
|
EA028382B1
(ru)
|
2012-03-23 |
2017-11-30 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Соединения для лечения спинальной мышечной атрофии
|
|
US8729263B2
(en)
|
2012-08-13 |
2014-05-20 |
Novartis Ag |
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
|
|
AU2013204200B2
(en)
|
2012-10-11 |
2016-10-20 |
Brandeis University |
Treatment of amyotrophic lateral sclerosis
|
|
DK2906696T4
(da)
|
2012-10-15 |
2023-02-27 |
Ionis Pharmaceuticals Inc |
Fremgangsmåder til modulering af c9orf72-ekspression
|
|
CA2898080C
(en)
*
|
2013-01-15 |
2018-01-09 |
Novartis Ag |
Use of alpha 7 nicotinic acetylcholine receptor agonists
|
|
JP6137336B2
(ja)
*
|
2013-01-15 |
2017-05-31 |
ノバルティス アーゲー |
ナルコレプシーの処置のためのアルファ７ニコチン性受容体アゴニストの使用
|
|
WO2014111837A1
(en)
*
|
2013-01-15 |
2014-07-24 |
Novartis Ag |
Use of alpha 7 nicotinic acetylcholine receptor agonists
|
|
ITMI20130063A1
(it)
*
|
2013-01-17 |
2014-07-18 |
Valier Alberto |
Dispositivo manuale per la raccolta dal suolo di frutti o altri oggetti
|
|
US9040712B2
(en)
|
2013-01-23 |
2015-05-26 |
Novartis Ag |
Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
|
|
EP3013345B1
(en)
|
2013-06-25 |
2017-11-22 |
F. Hoffmann-La Roche AG |
Compounds for treating spinal muscular atrophy
|
|
MX2020011652A
(es)
|
2013-07-31 |
2022-09-27 |
Novartis Ag |
Derivados de piridazina 1,4-disustituida, y su uso para el tratamiento de afecciones relacionadas con la deficiencia de smn.
|
|
CN105392790B
(zh)
|
2013-08-19 |
2019-04-19 |
豪夫迈·罗氏有限公司 |
4H-吡啶并[1,2-a]嘧啶-4-酮化合物制备用于预防或治疗癌症的药物的用途
|
|
WO2015031036A1
(en)
|
2013-08-26 |
2015-03-05 |
Purdue Pharma L.P. |
Azaspiro[4.5] decane derivatives and use thereof
|
|
US9982260B2
(en)
|
2013-09-30 |
2018-05-29 |
The Regents Of The University Of California |
Identification of structurally similar small molecules that enhance therapeutic exon skipping
|
|
US11162096B2
(en)
|
2013-10-14 |
2021-11-02 |
Ionis Pharmaceuticals, Inc |
Methods for modulating expression of C9ORF72 antisense transcript
|
|
HK1226064A1
(zh)
|
2014-03-14 |
2017-09-22 |
拉夸里亚创药株式会社 |
作为trpm8拮抗剂的氮杂螺衍生物
|
|
WO2015143245A1
(en)
|
2014-03-19 |
2015-09-24 |
Isis Pharmaceuticals, Inc. |
Methods for modulating ataxin 2 expression
|
|
WO2015190921A2
(en)
|
2014-06-10 |
2015-12-17 |
Erasmus University Medical Center Rotterdam |
Methods for characterizing alternatively or aberrantly spliced mrna isoforms
|
|
GB201410693D0
(en)
|
2014-06-16 |
2014-07-30 |
Univ Southampton |
Splicing modulation
|
|
WO2016027168A2
(en)
*
|
2014-08-20 |
2016-02-25 |
Lifesplice Pharma Llc |
Splice modulating oligonucleotides and methods of use thereof
|
|
WO2016037039A1
(en)
|
2014-09-04 |
2016-03-10 |
Rutgers, The State University Of New Jersey |
Compositions for increasing survival of motor neuron protein (smn) levels in target cells and methods of use thereof for the treatment of spinal muscular atrophy
|
|
US20170334977A1
(en)
|
2014-10-20 |
2017-11-23 |
The Brigham And Women's Hospital, Inc. |
Targeting Apolipoprotein E (APOE) in Neurologic Disease
|
|
US10053697B1
(en)
|
2015-01-09 |
2018-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Programmable alternative splicing devices and uses thereof
|
|
CN107257793A
(zh)
|
2015-01-20 |
2017-10-17 |
梅里亚股份有限公司 |
抗蠕虫化合物、组合物及其使用方法
|
|
EP3053577A1
(en)
|
2015-02-09 |
2016-08-10 |
F. Hoffmann-La Roche AG |
Compounds for the treatment of cancer
|
|
CN107428729B
(zh)
*
|
2015-02-09 |
2021-07-16 |
豪夫迈·罗氏有限公司 |
用于治疗癌症的化合物
|
|
US10668171B2
(en)
*
|
2015-05-30 |
2020-06-02 |
Ptc Therapeutics, Inc. |
Methods for modulating RNA splicing
|
|
CR20180109A
(es)
|
2015-07-20 |
2018-05-03 |
Genzyme Corp |
Inhibidores de receptor del factor estimulador de colonias 1 (csf-1r)
|
|
WO2017041036A1
(en)
|
2015-09-02 |
2017-03-09 |
Pathways Bioscience, Llc |
Compositions and methods for treatment or prevention of oral mucositis
|
|
US10358427B2
(en)
|
2015-09-24 |
2019-07-23 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of indoleamine 2,3-dioxygenase
|
|
WO2017062751A1
(en)
|
2015-10-08 |
2017-04-13 |
The Regents Of The University Of California |
Compounds and methods for promoting stress resistance
|
|
EP3359685A1
(en)
|
2015-10-09 |
2018-08-15 |
University Of Southampton |
Modulation of gene expression and screening for deregulated protein expression
|
|
KR102162062B1
(ko)
|
2015-11-12 |
2020-10-07 |
에프. 호프만-라 로슈 아게 |
척수성 근위축증의 치료용 조성물
|
|
WO2017100276A1
(en)
|
2015-12-08 |
2017-06-15 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for treatment, amelioration, and prevention of diabetes-related skin ulcers
|
|
CN113750101A
(zh)
*
|
2015-12-10 |
2021-12-07 |
Ptc医疗公司 |
用于治疗亨廷顿病的方法
|
|
US11096956B2
(en)
|
2015-12-14 |
2021-08-24 |
Stoke Therapeutics, Inc. |
Antisense oligomers and uses thereof
|
|
WO2017112956A1
(en)
|
2015-12-23 |
2017-06-29 |
Moonshot Pharma Llc |
Methods for inducing an immune response
|
|
US10787433B2
(en)
|
2016-01-15 |
2020-09-29 |
The Brigham And Women's Hospital, Inc. |
Pyridazine derivatives as EAAT2 activators
|
|
AU2017215201B2
(en)
*
|
2016-02-01 |
2023-10-19 |
Arrakis Therapeutics, Inc. |
Compounds and methods of treating RNA-mediated diseases
|
|
JP2019509272A
(ja)
|
2016-02-23 |
2019-04-04 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ |
脊髄性筋萎縮症の治療のための併用療法
|
|
US11674952B2
(en)
|
2016-02-24 |
2023-06-13 |
The Rockefeller University |
Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof
|
|
US11066456B2
(en)
|
2016-02-25 |
2021-07-20 |
Washington University |
Compositions comprising TREM2 and methods of use thereof
|
|
US20170268066A1
(en)
|
2016-03-15 |
2017-09-21 |
Chalmers Ventures Ab |
Cancer biomarkers
|
|
CN108779093B
(zh)
|
2016-03-29 |
2021-03-09 |
默克专利股份公司 |
作为丙酮酸脱氢酶激酶的抑制剂的n1-(3,3,3-三氟-2-羟基-2-甲基丙酰基)-哌啶衍生物
|
|
EP3440100A4
(en)
|
2016-04-04 |
2020-01-22 |
University of Florida Research Foundation, Incorporated |
HANDLING EIF3 TO MODULATE A NON-ATG TRANSLATION ASSOCIATED WITH A REPETITION (RAN)
|
|
EP3442960A1
(en)
|
2016-04-12 |
2019-02-20 |
Esteve Pharmaceuticals, S.A. |
Arylamide derivatives having multimodal activity against pain
|
|
EP3785728A3
(en)
|
2016-06-13 |
2021-04-28 |
Scholar Rock, Inc. |
Use of myostatin inhibitors and combination therapies
|
|
CN109563515A
(zh)
*
|
2016-07-01 |
2019-04-02 |
阿拉基斯医疗公司 |
化合物和调节rna功能的方法
|
|
EA201991309A1
(ru)
|
2016-11-28 |
2019-11-29 |
|
Способы модуляции сплайсинга рнк
|
|
CN110312528B
(zh)
|
2017-02-20 |
2022-02-18 |
国立大学法人京都大学 |
用于起因于剪接异常的遗传性疾病的药物组合物及治疗方法
|
|
US11715549B2
(en)
|
2017-05-01 |
2023-08-01 |
Thomas Jefferson University |
Systems-level analysis of 32 TCGA cancers reveals disease-dependent tRNA fragmentation patterns and very selective associations with messenger RNAs and repeat elements
|
|
CN111372611A
(zh)
*
|
2017-06-14 |
2020-07-03 |
Ptc医疗公司 |
修饰rna剪接的方法
|
|
EP3645121B8
(en)
|
2017-06-28 |
2025-06-18 |
PTC Therapeutics, Inc. |
Methods for treating huntington's disease
|
|
CA3067591A1
(en)
|
2017-06-28 |
2019-01-03 |
Ptc Therapeutics, Inc. |
Methods for treating huntington's disease
|
|
SG10202002990XA
(en)
*
|
2017-08-04 |
2020-05-28 |
Skyhawk Therapeutics Inc |
Methods and compositions for modulating splicing
|
|
WO2019057123A1
(zh)
|
2017-09-20 |
2019-03-28 |
杭州英创医药科技有限公司 |
作为ido抑制剂和/或ido-hdac双重抑制剂的多环化合物
|
|
EP3694848A1
(en)
|
2017-10-12 |
2020-08-19 |
Revolution Medicines, Inc. |
Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors
|
|
KR102705509B1
(ko)
|
2017-10-24 |
2024-09-12 |
상가모 테라퓨틱스, 인코포레이티드 |
희귀 질환의 치료를 위한 방법 및 조성물
|
|
EP3479845A1
(en)
|
2017-11-06 |
2019-05-08 |
Stalicla S.A. |
Challenge test for diagnosing subtype of autism spectrum disease
|
|
WO2019094694A1
(en)
|
2017-11-10 |
2019-05-16 |
University Of Massachusetts |
Compositions and methods for the treatment of expanded repeat-associated disorders
|
|
KR20210005559A
(ko)
|
2018-03-27 |
2021-01-14 |
피티씨 테라퓨틱스, 인크. |
헌팅턴병 치료 화합물
|
|
CN112272666A
(zh)
|
2018-04-10 |
2021-01-26 |
斯基霍克疗法公司 |
用于治疗癌症的化合物
|
|
LT3814357T
(lt)
|
2018-06-27 |
2024-06-25 |
Ptc Therapeutics, Inc. |
Heterocikliniai ir heteroarilų junginiai, skirti hantingtono ligos gydymui
|
|
US11685746B2
(en)
|
2018-06-27 |
2023-06-27 |
Ptc Therapeutics, Inc. |
Heteroaryl compounds for treating Huntington's disease
|
|
WO2020005877A1
(en)
|
2018-06-27 |
2020-01-02 |
Ptc Therapeutics, Inc. |
Heteroaryl compounds for treating huntington's disease
|
|
CN112469707B
(zh)
|
2018-06-27 |
2024-06-21 |
利伯纳生物科学株式会社 |
脊髓性肌萎缩症的预防剂或治疗剂
|
|
US11987568B2
(en)
|
2018-08-03 |
2024-05-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of WEE1 kinase
|
|
TW202028183A
(zh)
|
2018-10-10 |
2020-08-01 |
大陸商江蘇豪森藥業集團有限公司 |
含氮雜芳類衍生物調節劑、其製備方法和應用
|
|
US11129829B2
(en)
*
|
2019-06-17 |
2021-09-28 |
Skyhawk Therapeutics, Inc. |
Methods for modulating splicing
|
|
WO2021174176A1
(en)
|
2020-02-28 |
2021-09-02 |
Remix Therapeutics Inc. |
Pyridazine dervatives for modulating nucleic acid splicing
|
|
CA3169697A1
(en)
|
2020-02-28 |
2021-09-02 |
Dominic Reynolds |
Thiophenyl derivatives useful for modulating nucleic acid splicing
|
|
EP4110464A1
(en)
|
2020-02-28 |
2023-01-04 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
US20230148184A1
(en)
|
2020-02-28 |
2023-05-11 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
EP4132646A1
(en)
|
2020-04-08 |
2023-02-15 |
Remix Therapeutics Inc. |
Compounds and methods for modulating splicing
|
|
CA3175193A1
(en)
|
2020-04-08 |
2021-10-14 |
Dominic Reynolds |
Compounds and methods for modulating splicing
|